Computational Study of Gleevec and G6G Reveals Molecular Determinants of Kinase Inhibitor Selectivity

被引:47
作者
Lin, Yen-Lin [1 ]
Meng, Yilin [1 ]
Huang, Lei [1 ]
Roux, Benoit [1 ]
机构
[1] Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, Chicago, IL 60637 USA
基金
美国国家卫生研究院;
关键词
BINDING FREE-ENERGY; C-SRC; DYNAMICS SIMULATIONS; BCR-ABL; IMATINIB; RESISTANCE; CHARMM; POTENT; CONFORMATION; SPARSOMYCIN;
D O I
10.1021/ja504146x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Gleevec is a potent inhibitor of Abl tyrosine kinase but not of the highly homologous c-Src kinase. Because the ligand binds to an inactive form of the protein in which an Asp-Phe-Gly structural motif along the activation loop adopts a so-called DFG-out conformation, it was suggested that binding specificity was controlled by a "conformational selection" mechanism. In this context, the binding affinity displayed by the kinase inhibitor G6G poses an intriguing challenge. Although it possesses a chemical core very similar to that of Gleevec, G6G is a potent inhibitor of both Abl and c-Src kinases. Both inhibitors bind to the DFG-out conformation of the kinases, which seems to be in contradiction with the conformational selection mechanism. To address this issue and display the hidden thermodynamic contributions affecting the binding selectivity, molecular dynamics free energy simulations with explicit solvent molecules were carried out. Relative to Gleevec, G6G forms highly favorable van der Waals dispersive interactions upon binding to the kinases via its triazine functional group, which is considerably larger than the corresponding pyridine moiety in Gleevec. Upon binding of G6G to c-Src, these interactions offset the unfavorable free energy cost of the DFG-out conformation. When binding to Abl, however, G6G experiences an unfavorable free energy penalty due to steric clashes with the phosphate-binding loop, yielding an overall binding affinity that is similar to that of Gleevec. Such steric clashes are absent when G6G binds to c-Src, due to the extended conformation of the phosphate-binding loop.
引用
收藏
页码:14753 / 14762
页数:10
相关论文
共 54 条
[1]   Molecular Dynamics Simulations Show That Conformational Selection Governs the Binding Preferences of Imatinib for Several Tyrosine Kinases [J].
Aleksandrov, Alexey ;
Simonson, Thomas .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (18) :13807-13815
[2]   A Molecular Mechanics Model for Imatinib and Imatinib:Kinase Binding [J].
Aleksandrov, Alexey ;
Simonson, Thomas .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2010, 31 (07) :1550-1560
[3]   CHARMM: The Biomolecular Simulation Program [J].
Brooks, B. R. ;
Brooks, C. L., III ;
Mackerell, A. D., Jr. ;
Nilsson, L. ;
Petrella, R. J. ;
Roux, B. ;
Won, Y. ;
Archontis, G. ;
Bartels, C. ;
Boresch, S. ;
Caflisch, A. ;
Caves, L. ;
Cui, Q. ;
Dinner, A. R. ;
Feig, M. ;
Fischer, S. ;
Gao, J. ;
Hodoscek, M. ;
Im, W. ;
Kuczera, K. ;
Lazaridis, T. ;
Ma, J. ;
Ovchinnikov, V. ;
Paci, E. ;
Pastor, R. W. ;
Post, C. B. ;
Pu, J. Z. ;
Schaefer, M. ;
Tidor, B. ;
Venable, R. M. ;
Woodcock, H. L. ;
Wu, X. ;
Yang, W. ;
York, D. M. ;
Karplus, M. .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2009, 30 (10) :1545-1614
[4]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[5]   POLAR HYDROGEN POSITIONS IN PROTEINS - EMPIRICAL ENERGY PLACEMENT AND NEUTRON-DIFFRACTION COMPARISON [J].
BRUNGER, AT ;
KARPLUS, M .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1988, 4 (02) :148-156
[6]  
Buchdunger E, 1996, CANCER RES, V56, P100
[7]   Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia [J].
Cowan-Jacob, Sandra W. ;
Fendrich, Gabriele ;
Floersheimer, Andreas ;
Furet, Pascal ;
Liebetanz, Janis ;
Rummel, Gabriele ;
Rheinberger, Paul ;
Centeleghe, Mario ;
Fabbro, Doriano ;
Manley, Paul W. .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2007, 63 :80-93
[8]   Small Molecule Recognition of c-Src via the lmatinib-Binding Conformation [J].
Dar, Arvin C. ;
Lopez, Michael S. ;
Shokat, Kevan M. .
CHEMISTRY & BIOLOGY, 2008, 15 (10) :1015-1022
[9]   PARTICLE MESH EWALD - AN N.LOG(N) METHOD FOR EWALD SUMS IN LARGE SYSTEMS [J].
DARDEN, T ;
YORK, D ;
PEDERSEN, L .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (12) :10089-10092
[10]   The development of imatinib as a therapeutic agent for chronic myeloid leukemia [J].
Deininger, M ;
Buchdunger, E ;
Druker, BJ .
BLOOD, 2005, 105 (07) :2640-2653